As a consultant hepatologist and associate professor, I focus on rare liver diseases, particularly Wilson disease and other genetic or cholestatic liver conditions. I lead national and international collaborations and work with clinical trials, biomarker studies, gene therapy, and translational research to improve diagnosis and treatment.

My research explores copper metabolism, liver imaging, and genetic mechanisms in metabolic liver disorders. Using methods such as whole genome sequencing, multiple PET tracers, and biomarker analysis, I aim to improve diagnostics and enable targeted treatment. This research supports earlier detection and better care, especially for patients with complex or genetically unresolved conditions.

My primary responsibility is rare liver diseases, including Wilson disease, cholestatic and genetic liver disorders. I also take part in the clinical team managing liver transplant recipients and patients with liver cancer or neuroendocrine tumors. In addition, I contribute to international collaboration through the ERN Rare Liver network.